<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="case-report" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Iran J Med Sci</journal-id>
<journal-id journal-id-type="iso-abbrev">Iran J Med Sci</journal-id>
<journal-title-group>
<journal-title>Iranian Journal of Medical Sciences</journal-title>
</journal-title-group>
<issn pub-type="ppub">0253-0716</issn>
<issn pub-type="epub">1735-3688</issn>
<publisher>
<publisher-name>Iranian Journal of Medical Sciences</publisher-name>
<publisher-loc>Iran</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31439979</article-id>
<article-id pub-id-type="pmc">6661518</article-id>
<article-id pub-id-type="publisher-id">IJMS-44-4</article-id>
<article-id pub-id-type="doi">10.30476/IJMS.2019.44945</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case Reports</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Microduplication of Xp22.31 and <italic>MECP2</italic> Pathogenic Variant in a Girl with Rett Syndrome: A Case Report
</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Candelo</surname>
<given-names>Estephania</given-names>
<suffix> MD, MSc</suffix>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ramirez-Montaño</surname>
<given-names>Diana</given-names>
<suffix> MD, MSc</suffix>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pachajoa</surname>
<given-names>Harry</given-names>
<suffix> MD, PhD</suffix>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
</contrib-group>
<aff id="aff1">
<label>1</label>Center for Research on Congenital Anomalies and Rare Diseases (CIACER), Health Sciences Faculty, L Building, Universidad Icesi, Cali, Colombia;
</aff>
<aff id="aff2">
<label>2</label>Department of Genetics, Fundación Valle del Lili, Cali, Colombia
</aff>
<author-notes>
<corresp id="cor1"><bold>Correspondence:</bold>Harry Pachajoa, MD, PhD;
Center for Research on Congenital Anomalies and Rare Diseases (CIACER), Health Sciences Faculty, L Building, ZIP: 760031, Universidad Icesi, Cali, Colombia. <bold> Tel:</bold>+57 2 5552334, Ext: 8075, <bold> Fax:</bold>+57 2 5551441 </corresp>
<corresp id="cor2">E-mail : <email>hmpachajoa@icesi.edu.co </email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>7</month>
<year>2019</year>
</pub-date>
<volume>44</volume>
<issue>4</issue>
<fpage>347</fpage>
<lpage>353</lpage>
<history>
<date date-type="rev-recd">
<day>14</day>
<month>8</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>2</day>
<month>9</month>
<year>2018</year>
</date>
<date date-type="received">
<day>3</day>
<month>6</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright: © Iranian Journal of Medical Sciences</copyright-statement>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<abstract>
<p>Rett syndrome (RS) is a neurodevelopmental infantile disease characterized by an early normal psychomotor development followed by a regression in the acquisition of normal developmental stages. In the majority of cases, it leads to a sporadic mutation in the <italic>MECP2</italic> gene, which is located on the X chromosome. However, this syndrome has also been associated with microdeletions, gene translocations, and other gene mutations. A 12-year-old female Colombian patient was presented with refractory epilepsy and regression in skill acquisition (especially language with motor and verbal stereotypies, hyperactivity, and autistic spectrum disorder criteria). The patient was born to non-consanguineous parents and had an early normal development until the age of 36 months. Comparative genomic hybridization array-CGH (750K) was performed and Xp22.31 duplication was detected (6866889-8115153) with a size of 1.248 Mb associated with developmental delay, epilepsy, and autistic traits. Given the clinical criteria of RS, <italic>MECP2</italic> sequencing was performed which showed a de novo pathogenic variant c.338C&gt;G (p.Pro113Arg). The features of RS include intellectual disability, developmental delay, and autism. These features are associated with copy number variations (CNVs) on the X chromosome (Xp22.31 microduplication). Here we present the first reported case of simultaneous CNV and <italic>MECP2</italic> pathogenic mutation in a patient with RS. We propose that both DNA alterations might have a synergistic effect and could lead to variable expressivity of the phenotype.
</p>
</abstract>
<kwd-group>
<kwd>X-linked genetic disease </kwd>
<kwd> DNA copy number variations </kwd>
<kwd> Autism </kwd>
<kwd> Rett syndrome </kwd>
<kwd> Exome sequencing</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>
<bold>What’s Known</bold>
</p>
<p>
<list list-type="bullet"><list-item><p>Rett syndrome is a neurodevelopmental infantile disease characterized by an early normal psychomotor development followed by a regression in milestones. In the majority of cases, it leads to a sporadic mutation in the <italic>MECP2</italic> gene located on the X chromosome.
</p></list-item><list-item><p>
Xp22.31 microduplication is associated with developmental delay, epilepsy, and autistic traits.
</p></list-item></list>
</p>
<p>
<bold>What’s New</bold>
</p>
<p>
<list list-type="bullet"><list-item><p>For the first time, we clarified the pathogenicity of Xp22.31 microduplication. We propose that microduplication is an additional injury caused by a genetic factor or environmental disturbance.
</p></list-item><list-item><p>
The first reported case of simultaneous <italic>MECP2</italic> gene mutation and a microduplication of the Xp22.31 region.
</p></list-item></list>
</p>
<sec id="sec1-1" sec-type="Introduction">
<title>Introduction</title>
<p>RS (MIM: #312750) is a severe, progressive, neurodevelopmental, X-linked dominant disorder.<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> It is characterized by an early normal growth and neurodevelopment in the first 6 to 18 months of life with subsequent deceleration of growth and developmental regression involving loss of purposeful use of hands and verbal speech. Other common features are gait abnormalities, stereotypic movements, seizures, postnatal microcephaly, and intellectual disability (ID).<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> RS is diagnosed in accordance with the revised diagnostic criteria.<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> In most cases, it occurs in sporadic form and is the second genetic etiology of severe ID in women with a prevalence of 1:10,000-15,000 live female births.<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> Based on clinical criteria, there are two forms of RS, namely typical Rett and atypical Rett. Patients that meet all diagnostic criteria have typical Rett and a mutation in the <italic>MECP2</italic> gene is found in 97% of these cases. Those patients who do not meet all diagnostic criteria belong to the atypical Rett category in which only 50-70% of the cases are associated with mutations in the <italic>MECP2</italic> gene.<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> is known that <italic>MECP2</italic> protein binds to chromatin and could activate and inhibit gene transcription.<sup><xref ref-type="bibr" rid="ref3">3</xref>,<xref ref-type="bibr" rid="ref4">4</xref></sup> However, to date, the role of <italic>MECP2</italic> is not completely elucidated. 
</p>
<p>RS is a disease with a broad phenotypic spectrum and heterogeneous genetic components. Around 30 types of mutations in RS have been reported, including CDKL5/STK9 and NTNG genes.<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> The transcription factor <italic>FOXG1</italic> has also been associated as part of the genotype spectrum of this syndrome.<sup><xref ref-type="bibr" rid="ref5">5</xref></sup> Duplication and deletion of <italic>FOXG1</italic> have also been reported in individuals with Rett-like features, justifying chromosomal analysis in patients with probable RS.<sup><xref ref-type="bibr" rid="ref6">6</xref></sup></p>
<p>Xp22.31 duplication (from 6.4 to 8.1 Mb, hg19) has been described in various studies since 2004.<sup><xref ref-type="bibr" rid="ref7">7</xref>-<xref ref-type="bibr" rid="ref10">10</xref></sup> However, its clinical significance is currently unknown. Some studies have reported Xp22.31 duplication as a risk factor for ID.<sup><xref ref-type="bibr" rid="ref7">7</xref>-<xref ref-type="bibr" rid="ref9">9</xref></sup> It is found in 0.37%-0.46% of the cases and in 0.15%-0.41% of the controls or unaffected parents of the affected carriers.<sup><xref ref-type="bibr" rid="ref9">9</xref>,<xref ref-type="bibr" rid="ref10">10</xref></sup> This chromosomal rearrangement has been proposed as part of a clearly defined syndrome with the following features: ID, seizures, autism spectrum disorders (ASD), feeding problems, talipes, and hypotonia.<sup><xref ref-type="bibr" rid="ref7">7</xref></sup></p>
<p>We present a case of a 12-year-old girl with clinical criteria of typical RS and <italic>MECP2</italic> gene mutation associated with a microduplication of the Xp22.31 region. Such simultaneous mutations in a patient with RS have not been reported previously.
</p>
</sec>
<sec id="sec1-2" sec-type="Case Presentation">
<title>Case Presentation</title>
<p>A 12-year-old female patient was the fourth gestation of a 38-year-old mother and a non-consanguineous 31-year-old father, both without any significant
family history. There were no known exposures during pregnancy. The pregnancy was uncomplicated and antenatal ultrasounds were normal. Vaginal delivery
at the 37<sup>th</sup> week of gestation was without complications and the birth weight was 3.500 g (50<sup>th</sup> centile), length 57 cm (98<sup>th</sup> centile), and the head circumference
was 34 cm (50<sup>th</sup> centile) with an unremarkable neonatal period. Until the age of 36 months, her psychomotor development was normal, but then her mother noticed
that she was losing her acquired milestones. She stopped speaking and lost her purposeful hand skills around the age of 44 months. Additionally, she displayed
inappropriate laughing spells, a diminished response to pain, and episodes of hyperventilation. She started independent walking at the age of 11 months and never lost that ability. 
</p>
<p>The patient was referred from the Neurology Department to the Genetics Department for refractory epilepsy. At the age of 3, she had a simple untreated febrile seizure followed by a spontaneous generalized tonic-clonic seizure. Occasionally she experienced focal crisis as well as absence or tonic seizures. She underwent daily treatment with carbamazepine 10 mg/kg/d and clobazam 1 mg/kg without control. The last electroencephalogram (EEG) was performed at the age of 12 and it showed slowing background with spikes and slow waves in the central region during wakefulness. Furthermore, magnetic resonance imaging (MRI) of the brain revealed dilatation of the perivascular basal space without additional abnormalities. Chromatography of amino acids in the blood and organic acids in urine, hemogram, hepatic function test, and abdominal ultrasound were normal.
</p>
<p>The physical examination of the patient at the age of 12 revealed a normal head circumference and ID. She was unable to speak and the use of her hands was preserved, but hampered by stereotypic hand movements including mouthing, washing automatisms, and involuntary clapping. She had a slight dyspraxic gait, inappropriate visual contact, exhibited hyperactivity as well as hyperkeratosis in hands and fingers secondary to self-harm.
</p>
<p>High-resolution chromosomal microarray was performed using a 750K Affymetrix GeneChip 6.0 array. The results demonstrated a de novo 1.28 Mb microduplication in Xp22.31
(chrX:6866889-8115153) without inherited origin (<xref ref-type="fig" rid="IJMS-44-347-g001.tif">figure 1</xref>). This chromosomal rearrangement has not been associated with a genetic syndrome.
Her medical records were reviewed and RS was diagnosed (<xref ref-type="table" rid="T1">table 1</xref>).<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> A complete sequencing of <italic>MECP2</italic> (NM_004992.3) was performed and it showed a de novo variant c.338C&gt;G (p.Pro113Arg) as previously reported in ClinVar and HGMD databases and classified as likely pathogenic. Variant functional prediction software VARSOME (Human Genomic Variant Search Engine: https://varsome.com/) classified it as a damaging variant. This finding confirmed the clinical suspicion of RS. The carrier status of her parents was not confirmed due to the absence of symptoms.
</p>
<fig id="IJMS-44-347-g001.tif" position="float">
<label>Figure1</label>
<caption>
<p>Genetic findings in the patient. Array-CGH results showed a microduplication (green letters) in the Xp22.31 region and RefSeq genes. The <italic>MECP2</italic> sequencing showed a pathological change that led to a change in protein position 101 of proline-to-arginine (red letters). None of these changes were inherited from her parents.
</p>
</caption>
<graphic xlink:href="IJMS-44-347-g001"></graphic>
</fig>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p>A summary of clinical features in our patient in accordance with the revised diagnostic criteria (Neul 2010)</p>
</caption>
<table frame="hsides" rules="groups" width="100%">
<thead>
<tr style="background-color:#494c9f; color:#ffffff;">
<th align="left" colspan="2" rowspan="1" valign="top">Clinical criteria<xref ref-type="table-fn" rid="t1f1">*</xref></th>
<th align="left" colspan="1" rowspan="1" valign="top">Our patient</th>
</tr>
</thead>
<tbody>
<tr style="background-color:#f2f2f9; color:#231f20;">
<td align="left" colspan="1" rowspan="1" valign="top">Required</td>
<td align="left" colspan="1" rowspan="1" valign="top">A period of regression followed by recovery or stabilization</td>
<td align="left" colspan="1" rowspan="1" valign="top">Positive</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="4" valign="top">Main criteria</td>
<td align="left" colspan="1" rowspan="1" valign="top">Partial or complete loss of acquired purposeful hand skills</td>
<td align="left" colspan="1" rowspan="1" valign="top">Positive</td>
</tr>
<tr style="background-color:#f2f2f9; color:#231f20;">
<td align="left" colspan="1" rowspan="1" valign="top">Partial or complete loss of acquired spoken language</td>
<td align="left" colspan="1" rowspan="1" valign="top">Positive</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Gait abnormalities: Impaired (dyspraxia) or absence of ability</td>
<td align="left" colspan="1" rowspan="1" valign="top">Positive</td>
</tr>
<tr style="background-color:#f2f2f9; color:#231f20;">
<td align="left" colspan="1" rowspan="1" valign="top">Stereotypic hand movements such as hand wringing/squeezing, clapping/tapping, mouthing, and washing/rubbing automatisms</td>
<td align="left" colspan="1" rowspan="1" valign="top">Positive</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="11" valign="top">Supportive criteria</td>
<td align="left" colspan="1" rowspan="1" valign="top">Breathing disturbances when awake</td>
<td align="left" colspan="1" rowspan="1" valign="top">Negative</td>
</tr>
<tr style="background-color:#f2f2f9; color:#231f20;">
<td align="left" colspan="1" rowspan="1" valign="top">Bruxism when awake</td>
<td align="left" colspan="1" rowspan="1" valign="top">Positive</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Impaired sleep pattern</td>
<td align="left" colspan="1" rowspan="1" valign="top">Negative</td>
</tr>
<tr style="background-color:#f2f2f9; color:#231f20;">
<td align="left" colspan="1" rowspan="1" valign="top">Abnormal muscle tone</td>
<td align="left" colspan="1" rowspan="1" valign="top">Positive</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Peripheral vasomotor disturbances</td>
<td align="left" colspan="1" rowspan="1" valign="top">Negative</td>
</tr>
<tr style="background-color:#f2f2f9; color:#231f20;">
<td align="left" colspan="1" rowspan="1" valign="top">Scoliosis/kyphosis</td>
<td align="left" colspan="1" rowspan="1" valign="top">Negative</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Growth retardation</td>
<td align="left" colspan="1" rowspan="1" valign="top">Negative</td>
</tr>
<tr style="background-color:#f2f2f9; color:#231f20;">
<td align="left" colspan="1" rowspan="1" valign="top">Small cold hands and feet</td>
<td align="left" colspan="1" rowspan="1" valign="top">Negative</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Inappropriate laughing/screaming spells</td>
<td align="left" colspan="1" rowspan="1" valign="top">Positive</td>
</tr>
<tr style="background-color:#f2f2f9; color:#231f20;">
<td align="left" colspan="1" rowspan="1" valign="top">Diminished response to pain (supportive)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Positive</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Intense eye communication-“eye pointing” (supportive)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Negative</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="t1f1">
<label>*</label>
<p>Required for typical or classic RS: A period of regression followed by recovery or stabilization and the presence of all main criteria (excluding brain injury secondary to trauma, neurometabolic disease, or infection). Supportive criteria are not required, although often present in typical RS</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>A written informed consent was obtained from the patient’s parents for the publication of her images and clinical data for scientific purposes. 
</p>
</sec>
<sec id="sec1-3" sec-type="Discussion">
<title>Discussion</title>
<p>For the first time, we report a case of a simultaneous presence of the <italic>MECP2</italic> gene mutation associated with a CNV. As illustrated in <xref ref-type="fig" rid="IJMS-44-347-g002.tif">figure 2</xref>, there is a clinical overlap between patients with RS and with Xp22.31 microduplication. Mutations in the <italic>MECP2</italic> gene have the capacity to alter the chromatin. The Murine <italic>MECP2</italic> knockout model has shown an abnormal organization of heterochromatin during neural differentiation and an altered neurons morphology (fewer dendritic spines and relative less arborization).<sup><xref ref-type="bibr" rid="ref4">4</xref>,<xref ref-type="bibr" rid="ref11">11</xref></sup> An overload of a de novo high intragenic mutation has also been reported and was suggested to be related to CNVs. The regulatory function of the <italic>MECP2</italic> could modulate this phenotypic expression.<sup><xref ref-type="bibr" rid="ref3">3</xref>,<xref ref-type="bibr" rid="ref11">11</xref></sup></p>
<fig id="IJMS-44-347-g002.tif" position="float">
<label>Figure2</label>
<caption>
<p>The overlap between clinical features reported in patients with Xp22.31 microduplication and those diagnosed with RS.</p>
</caption>
<graphic xlink:href="IJMS-44-347-g002"></graphic>
</fig>
<p>Several studies, mostly single case reports and retrospective microarray analyses, have described microduplications of Xp22.31 (<xref ref-type="table" rid="T2">table 2</xref>).
Some studies have reported it as a benign variant<sup><xref ref-type="bibr" rid="ref9">9</xref>,<xref ref-type="bibr" rid="ref10">10</xref></sup> and some others have described
it as a risk factor for developmental delay.<sup><xref ref-type="bibr" rid="ref7">7</xref>-<xref ref-type="bibr" rid="ref9">9</xref></sup> The role of Xp22.31 microduplications
in causing an abnormal phenotype is controversial. Reduced penetrance, expression variability, involvement of multiple genes in the region, positional effect, X-inactivation
(21% of the genes on the X chromosome), and the presence of other CNVs or variants in the affected individuals may all contribute to phenotype variability. Additionally,
a benign variant can also behave differently in populations with different genetic backgrounds and could cause a pathological phenotype under certain conditions.<sup><xref ref-type="bibr" rid="ref9">9</xref></sup>
A previous study and one recent case report<sup><xref ref-type="bibr" rid="ref12">12</xref></sup> have suggested that Xp22.31 duplication might be a risk factor predisposing to a disease,
but clinical manifestation requires additional genetic changes having an additive effect.<sup><xref ref-type="bibr" rid="ref9">9</xref>,<xref ref-type="bibr" rid="ref12">12</xref></sup></p>
<table-wrap id="T2" position="float">
<label>Table 2</label>
<caption>
<p>Reported cases with Xp22.31 microduplication in comparison with our patients</p>
</caption>
<table frame="hsides" rules="groups" width="100%">
<thead>
<tr style="background-color:#494c9f; color:#ffffff;">
<th align="left" colspan="1" rowspan="1" valign="top"></th>
<th align="center" colspan="7" rowspan="1" valign="top">Xp22.31 microduplication</th>
<th align="center" colspan="2" rowspan="1" valign="top">Another mutation+Xp22.31 microduplication</th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">Literature</th>
<th align="left" colspan="1" rowspan="1" valign="top">Shafer et al.<sup><xref ref-type="bibr" rid="ref13">13</xref></sup> (2007)</th>
<th align="left" colspan="1" rowspan="1" valign="top">Wagenstaller et al.<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> (2007)</th>
<th align="left" colspan="1" rowspan="1" valign="top">Mencarelli et al. (2008)<sup><xref ref-type="bibr" rid="ref14">14</xref></sup></th>
<th align="left" colspan="1" rowspan="1" valign="top">Li et al.<sup><xref ref-type="bibr" rid="ref9">9</xref></sup> (2010)</th>
<th align="left" colspan="1" rowspan="1" valign="top">Liu et al.<sup><xref ref-type="bibr" rid="ref15">15</xref></sup> (2011)</th>
<th align="left" colspan="1" rowspan="1" valign="top">Faletra et al.<sup><xref ref-type="bibr" rid="ref8">8</xref></sup> (2012)</th>
<th align="left" colspan="1" rowspan="1" valign="top">Esplin et al.<sup><xref ref-type="bibr" rid="ref7">7</xref></sup> (2014)</th>
<th align="left" colspan="1" rowspan="1" valign="top">Qiao et al.<sup><xref ref-type="bibr" rid="ref12">12</xref></sup> (2018)</th>
<th align="left" colspan="1" rowspan="1" valign="top">Present case</th>
</tr>
</thead>
<tbody>
<tr style="background-color:#f2f2f9; color:#231f20;">
<td align="left" colspan="1" rowspan="1" valign="top">Sample</td>
<td align="left" colspan="1" rowspan="1" valign="top">n=5</td>
<td align="left" colspan="1" rowspan="1" valign="top">n=2</td>
<td align="left" colspan="1" rowspan="1" valign="top">n=2</td>
<td align="left" colspan="1" rowspan="1" valign="top">n=35</td>
<td align="left" colspan="1" rowspan="1" valign="top">n=14</td>
<td align="left" colspan="1" rowspan="1" valign="top">n=1</td>
<td align="left" colspan="1" rowspan="1" valign="top">n=9</td>
<td align="left" colspan="1" rowspan="1" valign="top">n=1</td>
<td align="left" colspan="1" rowspan="1" valign="top">n=1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Age (years)</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">20.5 (19-22)</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">From 14 months to 10 years</td>
<td align="left" colspan="1" rowspan="1" valign="top">12</td>
<td align="left" colspan="1" rowspan="1" valign="top">13.2 (3-19.5)</td>
<td align="left" colspan="1" rowspan="1" valign="top">19</td>
<td align="left" colspan="1" rowspan="1" valign="top">12</td>
</tr>
<tr style="background-color:#f2f2f9; color:#231f20;">
<td align="left" colspan="1" rowspan="1" valign="top">Abnormal perinatal period</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">0/1</td>
<td align="left" colspan="1" rowspan="1" valign="top">1/9</td>
<td align="left" colspan="1" rowspan="1" valign="top">0/1</td>
<td align="left" colspan="1" rowspan="1" valign="top">0/1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Diagnosed at age (years)</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">4</td>
<td align="left" colspan="1" rowspan="1" valign="top">9</td>
<td align="left" colspan="1" rowspan="1" valign="top">9</td>
<td align="left" colspan="1" rowspan="1" valign="top">12</td>
</tr>
<tr style="background-color:#f2f2f9; color:#231f20;">
<td align="left" colspan="1" rowspan="1" valign="top">Microcephaly</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">1/2</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">4/11</td>
<td align="left" colspan="1" rowspan="1" valign="top">1/14</td>
<td align="left" colspan="1" rowspan="1" valign="top">0/1</td>
<td align="left" colspan="1" rowspan="1" valign="top">1/8</td>
<td align="left" colspan="1" rowspan="1" valign="top">0/1</td>
<td align="left" colspan="1" rowspan="1" valign="top">1/1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Speech deficits</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">2/2</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">12/14</td>
<td align="left" colspan="1" rowspan="1" valign="top">1/1</td>
<td align="left" colspan="1" rowspan="1" valign="top">5/6</td>
<td align="left" colspan="1" rowspan="1" valign="top">1/1</td>
<td align="left" colspan="1" rowspan="1" valign="top">1/1</td>
</tr>
<tr style="background-color:#f2f2f9; color:#231f20;">
<td align="left" colspan="1" rowspan="1" valign="top">Developmental delay</td>
<td align="left" colspan="1" rowspan="1" valign="top">5/5</td>
<td align="left" colspan="1" rowspan="1" valign="top">1/2</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">24/35</td>
<td align="left" colspan="1" rowspan="1" valign="top">11/14</td>
<td align="left" colspan="1" rowspan="1" valign="top">1/1</td>
<td align="left" colspan="1" rowspan="1" valign="top">3/9</td>
<td align="left" colspan="1" rowspan="1" valign="top">1/1</td>
<td align="left" colspan="1" rowspan="1" valign="top">1/1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Intellectual disability</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">2/2</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">24/35</td>
<td align="left" colspan="1" rowspan="1" valign="top">8/14</td>
<td align="left" colspan="1" rowspan="1" valign="top">1/1</td>
<td align="left" colspan="1" rowspan="1" valign="top">9/9</td>
<td align="left" colspan="1" rowspan="1" valign="top">1/1</td>
<td align="left" colspan="1" rowspan="1" valign="top">1/1</td>
</tr>
<tr style="background-color:#f2f2f9; color:#231f20;">
<td align="left" colspan="1" rowspan="1" valign="top">Seizures</td>
<td align="left" colspan="1" rowspan="1" valign="top">1/5</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">4/35</td>
<td align="left" colspan="1" rowspan="1" valign="top">2/14</td>
<td align="left" colspan="1" rowspan="1" valign="top">1/1</td>
<td align="left" colspan="1" rowspan="1" valign="top">4/9</td>
<td align="left" colspan="1" rowspan="1" valign="top">0/1</td>
<td align="left" colspan="1" rowspan="1" valign="top">1/1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Sitting</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">3/3</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">1/1</td>
</tr>
<tr style="background-color:#f2f2f9; color:#231f20;">
<td align="left" colspan="1" rowspan="1" valign="top">Walking disability</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">2/3</td>
<td align="left" colspan="1" rowspan="1" valign="top">1/1</td>
<td align="left" colspan="1" rowspan="1" valign="top">1/1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Regression of developmental milestones</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">2/14</td>
<td align="left" colspan="1" rowspan="1" valign="top">0/1</td>
<td align="left" colspan="1" rowspan="1" valign="top">1/4</td>
<td align="left" colspan="1" rowspan="1" valign="top">0/1</td>
<td align="left" colspan="1" rowspan="1" valign="top">1/1</td>
</tr>
<tr style="background-color:#f2f2f9; color:#231f20;">
<td align="left" colspan="1" rowspan="1" valign="top">Feeding difficulty</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">7/35</td>
<td align="left" colspan="1" rowspan="1" valign="top">3/14</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">2/9</td>
<td align="left" colspan="1" rowspan="1" valign="top">1/1</td>
<td align="left" colspan="1" rowspan="1" valign="top">1/1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Autism spectrum disorder</td>
<td align="left" colspan="1" rowspan="1" valign="top">1/5</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">1/2</td>
<td align="left" colspan="1" rowspan="1" valign="top">9/35</td>
<td align="left" colspan="1" rowspan="1" valign="top">7/14</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">2/9</td>
<td align="left" colspan="1" rowspan="1" valign="top">0/1 (anxiety behavior)</td>
<td align="left" colspan="1" rowspan="1" valign="top">1/1</td>
</tr>
<tr style="background-color:#f2f2f9; color:#231f20;">
<td align="left" colspan="1" rowspan="1" valign="top">Hypotonia</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">7/35</td>
<td align="left" colspan="1" rowspan="1" valign="top">4/14</td>
<td align="left" colspan="1" rowspan="1" valign="top">1/1</td>
<td align="left" colspan="1" rowspan="1" valign="top">2/9</td>
<td align="left" colspan="2" rowspan="1" valign="top">1/1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">MRI abnormalities</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">1/2</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">3/14</td>
<td align="left" colspan="1" rowspan="1" valign="top">0/1</td>
<td align="left" colspan="1" rowspan="1" valign="top">1/3</td>
<td align="left" colspan="1" rowspan="1" valign="top">0/1</td>
<td align="left" colspan="1" rowspan="1" valign="top">1/1</td>
</tr>
<tr style="background-color:#f2f2f9; color:#231f20;">
<td align="left" colspan="1" rowspan="1" valign="top">Talipes Anomalies</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">1/1</td>
<td align="left" colspan="1" rowspan="1" valign="top">4/9</td>
<td align="left" colspan="1" rowspan="1" valign="top">0/1</td>
<td align="left" colspan="1" rowspan="1" valign="top">0/1</td>
</tr>
<tr>
<td align="left" colspan="10" rowspan="1" valign="top">Sex</td>
</tr>
<tr style="background-color:#f2f2f9; color:#231f20;">
<td align="left" colspan="1" rowspan="1" valign="top">Male</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">2/2</td>
<td align="left" colspan="1" rowspan="1" valign="top">0/2</td>
<td align="left" colspan="1" rowspan="1" valign="top">11/27</td>
<td align="left" colspan="1" rowspan="1" valign="top">11/14</td>
<td align="left" colspan="1" rowspan="1" valign="top">1/1</td>
<td align="left" colspan="1" rowspan="1" valign="top">5/9</td>
<td align="left" colspan="1" rowspan="1" valign="top">1/1</td>
<td align="left" colspan="1" rowspan="1" valign="top">0/1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Female</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">0/2</td>
<td align="left" colspan="1" rowspan="1" valign="top">2/2</td>
<td align="left" colspan="1" rowspan="1" valign="top">14/27</td>
<td align="left" colspan="1" rowspan="1" valign="top">3/14</td>
<td align="left" colspan="1" rowspan="1" valign="top">0/1</td>
<td align="left" colspan="1" rowspan="1" valign="top">4/9</td>
<td align="left" colspan="1" rowspan="1" valign="top">0/1</td>
<td align="left" colspan="1" rowspan="1" valign="top">1/1</td>
</tr>
<tr style="background-color:#f2f2f9; color:#231f20;">
<td align="left" colspan="1" rowspan="1" valign="top">Dysmorphic features: Face</td>
<td align="left" colspan="1" rowspan="1" valign="top">2/5</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">2/2</td>
<td align="left" colspan="1" rowspan="1" valign="top">17/35</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">1/1</td>
<td align="left" colspan="1" rowspan="1" valign="top">7/9</td>
<td align="left" colspan="1" rowspan="1" valign="top">1/1</td>
<td align="left" colspan="1" rowspan="1" valign="top">1/1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Short stature</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">1/2</td>
<td align="left" colspan="1" rowspan="1" valign="top">2/6</td>
<td align="left" colspan="1" rowspan="1" valign="top">2/14</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">4/8</td>
<td align="left" colspan="1" rowspan="1" valign="top">0/1</td>
<td align="left" colspan="1" rowspan="1" valign="top">1/1</td>
</tr>
<tr style="background-color:#f2f2f9; color:#231f20;">
<td align="left" colspan="1" rowspan="1" valign="top">Abnormal karyotype</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">0/2</td>
<td align="left" colspan="1" rowspan="1" valign="top">3/11</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">0/1</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">0/1</td>
<td align="left" colspan="1" rowspan="1" valign="top">0/1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Affected genes</td>
<td align="left" colspan="1" rowspan="1" valign="top">STS</td>
<td align="left" colspan="1" rowspan="1" valign="top">Between the VCX3A and VCX2 genes</td>
<td align="left" colspan="1" rowspan="1" valign="top">STS, KAL1</td>
<td align="left" colspan="1" rowspan="1" valign="top">VCX3A, HDHD1A, STS, VCX, PNPLA4</td>
<td align="left" colspan="1" rowspan="1" valign="top">VCX3A, HDHD1A, STS, VCX, PNPLA4, VCX2, VCX3B</td>
<td align="left" colspan="1" rowspan="1" valign="top">STS</td>
<td align="left" colspan="1" rowspan="1" valign="top">VCX3A, HDHD1A, STS, VCX, PNPLA4, KAL1</td>
<td align="left" colspan="1" rowspan="1" valign="top">VCX-A, PNLPA4</td>
<td align="left" colspan="1" rowspan="1" valign="top">(chrX:6866889-8115153) PUDP, STS, VCX, VCX2, PNLPA4</td>
</tr>
<tr style="background-color:#f2f2f9; color:#231f20;">
<td align="left" colspan="1" rowspan="1" valign="top">Size (Mb)</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">0.87 (0.6-1.13)</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">0.15 to 1.9</td>
<td align="left" colspan="1" rowspan="1" valign="top">0.35-1.9</td>
<td align="left" colspan="1" rowspan="1" valign="top">1.5</td>
<td align="left" colspan="1" rowspan="1" valign="top">0.77 (0.56-0.6)</td>
<td align="left" colspan="1" rowspan="1" valign="top">0.6</td>
<td align="left" colspan="1" rowspan="1" valign="top">1.24</td>
</tr>
<tr>
<td align="left" colspan="10" rowspan="1" valign="top">Status of inherited origin</td>
</tr>
<tr style="background-color:#f2f2f9; color:#231f20;">
<td align="left" colspan="1" rowspan="1" valign="top">Parents (maternal)</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">1/2</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">19/27</td>
<td align="left" colspan="1" rowspan="1" valign="top">3/14</td>
<td align="left" colspan="1" rowspan="1" valign="top">0/1</td>
<td align="left" colspan="1" rowspan="1" valign="top">4/9</td>
<td align="left" colspan="1" rowspan="1" valign="top">1/1</td>
<td align="left" colspan="1" rowspan="1" valign="top">0/1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">De novo</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">1/2</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">1/27</td>
<td align="left" colspan="1" rowspan="1" valign="top">11/14</td>
<td align="left" colspan="1" rowspan="1" valign="top">1/1</td>
<td align="left" colspan="1" rowspan="1" valign="top">5/9</td>
<td align="left" colspan="1" rowspan="1" valign="top">0/1</td>
<td align="left" colspan="1" rowspan="1" valign="top">1/1</td>
</tr>
<tr style="background-color:#f2f2f9; color:#231f20;">
<td align="left" colspan="1" rowspan="1" valign="top">Additional mutation</td>
<td align="left" colspan="7" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">PURA c.563T&gt;C; p.Ile188Thr</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>MECP2</italic> c.338C&gt;G; p.Pro113Arg</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>NA: Not available</p>
</table-wrap-foot>
</table-wrap>
<p>CNVs of genes on the X chromosome can contribute to the deregulation of normal cognitive development.<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> Position effect resulting in altered long-range regulation of genes in proximity to the area of duplication, as a possible mechanism for the described phenotypes, can account for the lack of a minimum common region of duplication among patients.<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> In conclusion, the absence or low frequency of Xp22.31 microduplication in a healthy population increases the confidence about its pathogenicity (<xref ref-type="table" rid="T2">Table 2</xref>) related to ID and minor facial dimorphisms.
<sup><xref ref-type="bibr" rid="ref7">7</xref>,<xref ref-type="bibr" rid="ref9">9</xref></sup></p>
<p>Li and colleagues reported 29 patients with developmental delay, autism, and ID with Xp22.31 microduplication.<sup><xref ref-type="bibr" rid="ref9">9</xref></sup> In all cases, duplication included the STS gene, which encodes steroid sulfatase, an enzyme that hydrolyzes the 3-beta-hydroxysteroid sulfate neurosteroids precursor, which affects normal neurophysiologic function<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> and behavioral processes linked with ID. The association between STS deficiency and susceptibility to attention deficit and hyperactivity disorder (ADHD), autism, and social communication deficits is known.<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> VCX3A is another well-studied gene in this region. It is associated with an abnormal neurocognitive phenotype, which plays a role in neurogenesis regulation.<sup><xref ref-type="bibr" rid="ref11">11</xref></sup> PNPLA4, another gene in this region, is related to human obesity.<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> Both the PNPLA4 and STS genes have been shown to escape X-inactivation.<sup><xref ref-type="bibr" rid="ref18">18</xref></sup> Considering the above, this mechanism could be significant in the phenotypic expression of this duplication. 
</p>
<p>The affected region in our patient (<xref ref-type="fig" rid="IJMS-44-347-g001.tif">figure 1</xref>) also contained two microRNA (MIR651 and MIR4767) and PUDP genes, which codifies for pseudouridine-5’-phosphatas;<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> non-disease associated until now. In addition, the distal portion of the short arm of the human X chromosome (Xp22.3) is a region that undergoes frequent genomic rearrangements. In the pseudoautosomal region PAR1, an obligatory recombination occurs in every male meiosis to maintain the homology between the X and Y chromosomes.<sup><xref ref-type="bibr" rid="ref18">18</xref></sup> It is possible that this genomic instability is a feature of the human Xp22.31 region and suggests that the microduplication might serve as a risk factor for neurological diseases.
</p>
</sec>
<sec id="sec1-4" sec-type="Conclusion">
<title>Conclusion</title>
<p>Additional genetic events should be considered when CNVs of uncertain clinical relevance are noted in diagnostic investigations. In particular, those with severe phenotypes associated with Xp22.31 duplication should be investigated to rule out more likely genetic causes of ID. Further studies are required to elucidate the specific role of the Xp22.31 region in neurogenetic disorders and to clarify its pathogenicity. We propose that microduplication can have an additive or synergistic effect and may generate a worse phenotype in the presence of other genomic alterations like the <italic>MECP2</italic> mutation. Disruption of regulatory regions and chromatin condensation induced by the <italic>MECP2</italic> gene could explain DNA breakage.
</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgement</title>
<p>
We would like to thank the family of the patient for their participation and Tobias Yates for editing the manuscript.
</p>
<p>
<bold>Conflict of Interest:</bold>None declared.
</p>
</ack>
<ref-list>
<title>References</title>
<ref id="ref1">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neul</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Kaufmann</surname>
<given-names>WE</given-names>
</name>
<name>
<surname>Glaze</surname>
<given-names>DG</given-names>
</name>
<name>
<surname>Christodoulou</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Bahi-Buisson</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Rett syndrome: revised diagnostic criteria and nomenclature</article-title>
<source/> Ann Neurol
          <year> 2010</year>
<volume>68</volume>
<fpage>944</fpage>
<lpage>50</lpage>
<comment>[<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMCPMC3058521">PMC Free Article</ext-link>]</comment>
<pub-id pub-id-type="doi">10.1002/ana.22124</pub-id>
<pub-id pub-id-type="pmid">21154482</pub-id>
</element-citation>
</ref>
<ref id="ref2">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laurvick</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>de Klerk</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Bower</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Christodoulou</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ravine</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Ellaway</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Rett syndrome in Australia: a review of the epidemiology</article-title>
<source/> J Pediatr
          <year> 2006</year>
<volume>148</volume>
<fpage>347</fpage>
<lpage>52</lpage>
<pub-id pub-id-type="doi">10.1016/j.jpeds.2005.10.037</pub-id>
<pub-id pub-id-type="pmid">16615965</pub-id>
</element-citation>
</ref>
<ref id="ref3">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lombardi</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Zoghbi</surname>
<given-names>HY</given-names>
</name>
</person-group>
<article-title>MECP2 disorders: from the clinic to mice and back</article-title>
<source/> J Clin Invest
          <year> 2015</year>
<volume>125</volume>
<fpage>2914</fpage>
<lpage>23</lpage>
<comment>[<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMCPMC4563741">PMC Free Article</ext-link>]</comment>
<pub-id pub-id-type="doi">10.1172/JCI78167</pub-id>
<pub-id pub-id-type="pmid">26237041</pub-id>
</element-citation>
</ref>
<ref id="ref4">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jin</surname>
<given-names>XR</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>XS</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>MeCP2 Deficiency in Neuroglia: New Progress in the Pathogenesis of Rett Syndrome</article-title>
<source/> Front Mol Neurosci
          <year> 2017</year>
<volume>10</volume>
<fpage>316</fpage>
<comment>[<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMCPMC5632713">PMC Free Article</ext-link>]</comment>
<pub-id pub-id-type="doi">10.3389/fnmol.2017.00316</pub-id>
<pub-id pub-id-type="pmid">29046627</pub-id>
</element-citation>
</ref>
<ref id="ref5">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mencarelli</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Spanhol-Rosseto</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Artuso</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Rondinella</surname>
<given-names>D</given-names>
</name>
<name>
<surname>De Filippis</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Bahi-Buisson</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Novel FOXG1 mutations associated with the congenital variant of Rett syndrome</article-title>
<source/> J Med Genet
          <year> 2010</year>
<volume>47</volume>
<fpage>49</fpage>
<lpage>53</lpage>
<pub-id pub-id-type="doi">10.1136/jmg.2009.067884</pub-id>
<pub-id pub-id-type="pmid">19578037</pub-id>
</element-citation>
</ref>
<ref id="ref6">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vineeth</surname>
<given-names>VS</given-names>
</name>
<name>
<surname>Dutta</surname>
<given-names>UR</given-names>
</name>
<name>
<surname>Tallapaka</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Das Bhowmik</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Dalal</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Whole exome sequencing identifies a novel 5Mb deletion at 14q12 region in a patient with global developmental delay, microcephaly and seizures</article-title>
<source/> Gene
          <year> 2018</year>
<volume>673</volume>
<fpage>56</fpage>
<lpage>60</lpage>
<pub-id pub-id-type="doi">10.1016/j.gene.2018.06.045</pub-id>
<pub-id pub-id-type="pmid">29920362</pub-id>
</element-citation>
</ref>
<ref id="ref7">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Esplin</surname>
<given-names>ED</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Slavotinek</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Novelli</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Battaglia</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Nine patients with Xp22.31 microduplication, cognitive deficits, seizures, and talipes anomalies</article-title>
<source/>Am J Med Genet A 
          <year> 2014</year>
<volume>164A</volume>
<fpage>2097</fpage>
<lpage>103</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.36598</pub-id>
<pub-id pub-id-type="pmid">24800990</pub-id>
</element-citation>
</ref>
<ref id="ref8">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Faletra</surname>
<given-names>F</given-names>
</name>
<name>
<surname>D’Adamo</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Santa Rocca</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Carrozzi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Perrone</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Pecile</surname>
<given-names>V</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Does the 1.5 Mb microduplication in chromosome band Xp22.31 have a pathogenetic role? New contribution and a review of the literature</article-title>
<source/>Am J Med Genet A
          <year> 2012</year>
<volume>158A</volume>
<fpage>461</fpage>
<lpage>4</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.34398</pub-id>
<pub-id pub-id-type="pmid">22140086</pub-id>
</element-citation>
</ref>
<ref id="ref9">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kohler</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Sharkey</surname>
<given-names>FH</given-names>
</name>
<name>
<surname>Menon</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Coulleaux</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Interstitial microduplication of Xp22.31: Causative of intellectual disability or benign copy number variant?</article-title>
<source/> Eur J Med Genet
          <year> 2010</year>
<volume>53</volume>
<fpage>93</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejmg.2010.01.004</pub-id>
<pub-id pub-id-type="pmid">20132918</pub-id>
</element-citation>
</ref>
<ref id="ref10">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wagenstaller</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Spranger</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lorenz-Depiereux</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Kazmierczak</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Nathrath</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wahl</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Copy-number variations measured by single-nucleotide-polymorphism oligonucleotide arrays in patients with mental retardation</article-title>
<source/> Am J Hum Genet
          <year> 2007</year>
<volume>81</volume>
<fpage>768</fpage>
<lpage>79</lpage>
<comment>[<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMCPMC2227926">PMC Free Article</ext-link>]</comment>
<pub-id pub-id-type="doi">10.1086/521274</pub-id>
<pub-id pub-id-type="pmid">17847001</pub-id>
</element-citation>
</ref>
<ref id="ref11">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sajan</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Jhangiani</surname>
<given-names>SN</given-names>
</name>
<name>
<surname>Muzny</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Gibbs</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Lupski</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Glaze</surname>
<given-names>DG</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Enrichment of mutations in chromatin regulators in people with Rett syndrome lacking mutations in MECP2</article-title>
<source/> Genet Med
          <year> 2017</year>
<volume>19</volume>
<fpage>13</fpage>
<lpage>9</lpage>
<comment>[<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMCPMC5107176">PMC Free Article</ext-link>]</comment>
<pub-id pub-id-type="doi">10.1038/gim.2016.42</pub-id>
<pub-id pub-id-type="pmid">27171548</pub-id>
</element-citation>
</ref>
<ref id="ref12">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qiao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Bagheri</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Badduke</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Martell</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>SME</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Exome sequencing identified a de novo mutation of PURA gene in a patient with familial Xp22.31 microduplication</article-title>
<source/>Eur J Med Genet
          <year> 2018</year>
<pub-id pub-id-type="doi">10.1016/j.ejmg.2018.06.010</pub-id>
<pub-id pub-id-type="pmid">29908350</pub-id>
</element-citation>
</ref>
<ref id="ref13">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shaffer</surname>
<given-names>LG</given-names>
</name>
<name>
<surname>Bejjani</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Torchia</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Kirkpatrick</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Coppinger</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ballif</surname>
<given-names>BC</given-names>
</name>
</person-group>
<article-title>The identification of microdeletion syndromes and other chromosome abnormalities: cytogenetic methods of the past, new technologies for the future</article-title>
<source/> Am J Med Genet C Semin Med Genet
          <year> 2007</year>
<volume>145C</volume>
<fpage>335</fpage>
<lpage>45</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.c.30152</pub-id>
<pub-id pub-id-type="pmid">17910076</pub-id>
</element-citation>
</ref>
<ref id="ref14">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mencarelli</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Katzaki</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Papa</surname>
<given-names>FT</given-names>
</name>
<name>
<surname>Sampieri</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Caselli</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Uliana</surname>
<given-names>V</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Private inherited microdeletion/microduplications: implications in clinical practice</article-title>
<source/> Eur J Med Genet
          <year> 2008</year>
<volume>51</volume>
<fpage>409</fpage>
<lpage>16</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejmg.2008.06.003</pub-id>
<pub-id pub-id-type="pmid">18657637</pub-id>
</element-citation>
</ref>
<ref id="ref15">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Erez</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Nagamani</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Bi</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Carvalho</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Simmons</surname>
<given-names>AD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Copy number gain at Xp22.31 includes complex duplication rearrangements and recurrent triplications</article-title>
<source/>Hum Mol Genet
          <year> 2011</year>
<volume>20</volume>
<fpage>1975</fpage>
<lpage>88</lpage>
<comment>[<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMCPMC3080608">PMC Free Article</ext-link>]</comment>
<pub-id pub-id-type="doi">10.1093/hmg/ddr078</pub-id>
<pub-id pub-id-type="pmid">21355048</pub-id>
</element-citation>
</ref>
<ref id="ref16">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Froyen</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Van Esch</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Bauters</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hollanders</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Frints</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Vermeesch</surname>
<given-names>JR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Detection of genomic copy number changes in patients with idiopathic mental retardation by high-resolution X-array-CGH: important role for increased gene dosage of XLMR genes</article-title>
<source/> Hum Mutat
          <year> 2007</year>
<volume>28</volume>
<fpage>1034</fpage>
<lpage>42</lpage>
<pub-id pub-id-type="doi">10.1002/humu.20564</pub-id>
<pub-id pub-id-type="pmid">17546640</pub-id>
</element-citation>
</ref>
<ref id="ref17">
<label>17</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Preumont</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rzem</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Vertommen </surname>
<given-names>D</given-names>
</name>
<name>
<surname>Van Schaftingen </surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>HDHD1, which is often deleted in X-linked ichthyosis, encodes a pseudouridine-5’-phosphatase</article-title>
<source/>Biochem J
          <year> 2010</year>
<volume>431</volume>
<fpage>237</fpage>
<lpage>44</lpage>
<pub-id pub-id-type="doi">10.1042/BJ20100174</pub-id>
<pub-id pub-id-type="pmid">20722631</pub-id>
</element-citation>
</ref>
<ref id="ref18">
<label>18</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carrel </surname>
<given-names>L</given-names>
</name>
<name>
<surname>Willard </surname>
<given-names>HF</given-names>
</name>
</person-group>
<article-title>X-inactivation profile reveals extensive variability in X-linked gene expression in females</article-title>
<source/>Nature
          <year> 2005</year>
<volume>434</volume>
<fpage>400</fpage>
<lpage>4</lpage>
<pub-id pub-id-type="doi">10.1038/nature03479</pub-id>
<pub-id pub-id-type="pmid">15772666</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>